newsfilter
← Latest News
GlobeNewswire·

Synlogic Reports Second Quarter 2024 Financial Results

WINCHESTER, Mass., Aug. 08, 2024 (GLOBE NEWSWIRE) -- Synlogic, Inc. (NASDAQ:SYBX), a biopharmaceutical company advancing novel therapeutics to transform the care of serious diseases, today reported financial results